A1Cantus vs. Placebo

Double-Blind Randomized Controlled Trial of A1Cantus Drink vs. Placebo for Reduction of Ha1c

The investigators will conduct a randomized controlled 2-arm parallel trial of A1c Drink vs. Placebo over a 3-month period and compare changes in Ha1c from baseline to 3 months. Investigator and study personnel, as well as participants, will be blinded to drink assignments.

Inclusion Criteria:

• Adults 21 years of age or older and not older than 75 recruited from UCR Health
• Clinical diagnosis of type II DM with Ha1c >= 8 but less than or equal to 10
• Stable medications for at least 6 months
• Speak Spanish and/or English
• Sign an informed consent form
• No other members in their household are participating in the study

Exclusion Criteria:

• Patients <21 years of age, who do not have type II DM, whose Ha1c is less than 8 or > 10,
• Have major complications of diabetes, including CKD, diabetic retinopathy, ADVD risk > 5, or history of CVD/stroke
• Do not speak and understand either English or Spanish well
• Allergic to cinnamon
• Severe diseases, such as cancer
• Compromised immune system
• Eating disorders
• BMI of 40 or higher
• Already have a family member participating in the study
• Substance use disorder